EASL 2012 Conference Review - reviewed by Dr Alexander Thompson

In this review:

Will GS-7977 end response- guided therapy in HCV GT1?
Using PEG-based therapy in advanced liver disease
Telaprevir and boceprevir in the post-transplant setting
IFN-free GS-7977/RBV: consistent antiviral suppression
IFN-free regimens p

Please login below to download this issue (PDF)